Mindbloom is the largest national provider of psychedelic therapy, focusing on transforming mental health and wellness through scientifically-backed treatments. Established in 2018, the organization offers a comprehensive at-home ketamine therapy program aimed at improving access and outcomes for individuals dealing with anxiety and depression. With over 250,000 treatments provided annually across 38 states, Mindbloom seeks to mainstream psychedelic medicine as an effective alternative to traditional therapies. The company's mission is supported by a team of experienced professionals including industry pioneers, creating a culture centered on freedom, responsibility, and intellectual honesty. Mindbloom is committed to a remote-first, asynchronous work environment that prioritizes employee well-being while striving to make a significant impact on global mental health challenges.